Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
March 14, 2023 at 11:00 AM EDT
Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
